Answers are grounded in this paper and cite their sources.
models that enrich for GBM stem cells (GSCs), a subpopulation of tumor cells with stem cell-like properties that recapitulate the cellular heterogeneity of its parental tumor and resist conventional therapy and seed disease relapse. For complete details on the use and execution of this protocol, please refer to Vora et al. (2020).
No takes yet. Share an insight, caveat, or question.
Chokshi et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: